O
BAX icon

OrbiMed’s Baxter International BAX Stock Holding History

OrbiMed’s Portfolio BAX Stock Details BAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,239,900
Closed -$84.5M – 117
2023
Q3 		$84.5M Sell
2,239,900
-1,135,100
-34% -$48.4M 1.8% 16
2023
Q2 		$154M Buy
3,375,000
+1,813,000
+116% +$79M 2.79% 8
2023
Q1 		$63.4M Buy
+1,562,000
New +$66.2M 1.24% 25
2015
Q4 		– Sell
-319,000
Closed -$10.5M – 131
2015
Q3 		$10.5M Buy
+319,000
New +$12.1M 0.11% 91
2015
Q2 		– Sell
-526,894
Closed -$19.6M – 139
2015
Q1 		$19.6M Buy
+526,894
New +$20M 0.17% 81
2014
Q1 		– Sell
-449,204
Closed -$17M – 142
2013
Q4 		$17M Buy
449,204
+149,489
+50% +$5.42M 0.25% 68
2013
Q3 		$10.7M Hold
299,715
– – 0.19% 75
2013
Q2 		$11.3M Buy
+299,715
New +$11.5M 0.24% 73

Other funds holding BAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

OrbiMed's BAX Position: Q4 2023 in Review

OrbiMed sold out of Baxter International (BAX) in Q4 2023, closing a stake of 2,239,900 shares — an estimated $84.5M sold.

OrbiMed first reported a position in BAX in Q2 2013 and held it in 8 quarters. The position peaked at $154M in Q2 2023. 913 funds tracked by Wall St. Rank hold BAX as of Q4 2023.

  • OrbiMed reported no remaining Baxter International position as of Q4 2023 after selling out during the quarter.
  • OrbiMed sold 2,239,900 Baxter International shares in Q4 2023, an estimated $84.5M.
  • OrbiMed first reported a position in Baxter International in Q2 2013 and held it in 8 quarters.
  • OrbiMed's Baxter International position peaked at $154M in Q2 2023.
  • 913 funds tracked by Wall St. Rank held Baxter International as of Q4 2023.

Based on OrbiMed's 13F filing for Q4 2023, filed 14 Feb 2024.